This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
The Research to Accelerate Cures and Equity for Children Act recently went into effect, potentially paving the way for more drug development in pediatric cancers. The legislation will tighten the requirements for testing cancer agents used in adults to treat malignancies in children when there is a shared molecular target.
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
October 2020
Volume 10, Issue 10
Volume 10, Issue 10
RACE Act Poised to Advance Pediatric Cancer Research
Jump to section
Advertisement